Skip to main content

Cardiologists, Hospitals Seen Under Microscope as Costs Targeted By Susan Kelly CHICAGO (Reuters) Aug 09 - Investors in U.S. hospital companies can expect more scrutiny of billing practices and the medical need for expensive treatments as the federal government faces greater pressure to recoup billions in fraudulent claims, analysts said. And cardiology practices are ripe for scrutiny as treatments like implantable defibrillators and stents are costly, while new research shows that procedures involving medical devices may not be better than cheaper pills in many cases. "The ongoing scrutiny of those procedures is just part of doing business in the cardiovascular area today," UBS analyst A.J. Rice said. "I do see more companies disclosing they've gotten inquiries from the government and more media attention." HCA Holdings Inc, the largest for-profit hospital operator in the United States, said earlier this week that federal authorities were investigating whether heart procedures performed at some of its facilities were medically necessary. This isn't the first time that HCA has been in the government's crosshairs. Between 2000 and 2003, HCA paid a total of $1.7 billion in civil penalties and criminal fines to settle a massive federal investigation into fraudulent billing practices. Since then, the U.S. Justice Department has made identifying fraudulent medical claims and unnecessary treatment a higher priority as the nation's $2.6 trillion healthcare system contributes to a skyrocketing national deficit. False claims to the government's Medicare plan for the elderly are estimated to cost $60 billion a year. Arrests of people accused of bilking Medicare and other programs have centered on individual doctors, nurses and administrators in recent months. But Wall Street analysts expect that pursuit will put more public companies under the microscope. "That's the environment we're in. It's just simply going to intensify. Fighting Medicare fraud is the only true bipartisan issue," CRT Capital Group analyst Sheryl Skolnick said. "We're going to have to get used to the fact that more people are going to be subpoenaed, but not everyone is a crook." President Barack Obama's healthcare law provides an extra $300 million to crack down on Medicare waste and abuse over the next 10 years. The law gives the government more authority to oversee companies participating in federal health insurance programs. The government has put extra fraud-fighting resources into several regions of the country, including south Florida, Los Angeles, Houston, Detroit and New York City's Brooklyn borough. Last month, it launched a partnership with private insurance companies, including Humana Inc and UnitedHealth Group, to share data on medical claims. "The government is obviously showing that they're going to be as aggressive as legally possible to combat fraud," said Michael Williams, spokesman for the National Health Care Anti-Fraud Association, a coalition of health insurers and law enforcement. Tenet Healthcare Corp, the No. 3 U.S. hospital operator, said this week it has introduced systems to prevent unnecessary medical procedures. In 2003, Tenet agreed to pay a $54 million fine to settle allegations that two doctors at one of its California hospitals performed unneeded cardiac procedures.


By Susan Kelly
CHICAGO (Reuters) Aug 09 - Investors in U.S. hospital companies can expect more scrutiny of billing practices and the medical need for expensive treatments as the federal government faces greater pressure to recoup billions in fraudulent claims, analysts said.
And cardiology practices are ripe for scrutiny as treatments like implantable defibrillators and stents are costly, while new research shows that procedures involving medical devices may not be better than cheaper pills in many cases.
"The ongoing scrutiny of those procedures is just part of doing business in the cardiovascular area today," UBS analyst A.J. Rice said. "I do see more companies disclosing they've gotten inquiries from the government and more media attention."
HCA Holdings Inc, the largest for-profit hospital operator in the United States, said earlier this week that federal authorities were investigating whether heart procedures performed at some of its facilities were medically necessary.
This isn't the first time that HCA has been in the government's crosshairs.
Between 2000 and 2003, HCA paid a total of $1.7 billion in civil penalties and criminal fines to settle a massive federal investigation into fraudulent billing practices.
Since then, the U.S. Justice Department has made identifying fraudulent medical claims and unnecessary treatment a higher priority as the nation's $2.6 trillion healthcare system contributes to a skyrocketing national deficit. False claims to the government's Medicare plan for the elderly are estimated to cost $60 billion a year.
Arrests of people accused of bilking Medicare and other programs have centered on individual doctors, nurses and administrators in recent months. But Wall Street analysts expect that pursuit will put more public companies under the microscope.
"That's the environment we're in. It's just simply going to intensify. Fighting Medicare fraud is the only true bipartisan issue," CRT Capital Group analyst Sheryl Skolnick said. "We're going to have to get used to the fact that more people are going to be subpoenaed, but not everyone is a crook."
President Barack Obama's healthcare law provides an extra $300 million to crack down on Medicare waste and abuse over the next 10 years. The law gives the government more authority to oversee companies participating in federal health insurance programs.
The government has put extra fraud-fighting resources into several regions of the country, including south Florida, Los Angeles, Houston, Detroit and New York City's Brooklyn borough. Last month, it launched a partnership with private insurance companies, including Humana Inc and UnitedHealth Group, to share data on medical claims.
"The government is obviously showing that they're going to be as aggressive as legally possible to combat fraud," said Michael Williams, spokesman for the National Health Care Anti-Fraud Association, a coalition of health insurers and law enforcement.
Tenet Healthcare Corp, the No. 3 U.S. hospital operator, said this week it has introduced systems to prevent unnecessary medical procedures.
In 2003, Tenet agreed to pay a $54 million fine to settle allegations that two doctors at one of its California hospitals performed unneeded cardiac procedures.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease entity in